GETI.B

195.2

+0.46%↑

ATT

102.8

-0.39%↓

AMBEA

135.1

+0.6%↑

ARJOB

26.24

+1.55%↑

MSON.B

10.7

-0.93%↓

GETI.B

195.2

+0.46%↑

ATT

102.8

-0.39%↓

AMBEA

135.1

+0.6%↑

ARJOB

26.24

+1.55%↑

MSON.B

10.7

-0.93%↓

GETI.B

195.2

+0.46%↑

ATT

102.8

-0.39%↓

AMBEA

135.1

+0.6%↑

ARJOB

26.24

+1.55%↑

MSON.B

10.7

-0.93%↓

GETI.B

195.2

+0.46%↑

ATT

102.8

-0.39%↓

AMBEA

135.1

+0.6%↑

ARJOB

26.24

+1.55%↑

MSON.B

10.7

-0.93%↓

GETI.B

195.2

+0.46%↑

ATT

102.8

-0.39%↓

AMBEA

135.1

+0.6%↑

ARJOB

26.24

+1.55%↑

MSON.B

10.7

-0.93%↓

Home・Elenco Azioni・Vivesto AB

Vivesto AB

Chiusa

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

Massimo

Metriche Chiave
By Trading Economics
Entrata	-1.9M -9.1M
EPS	-0.013
Dipendenti	4
EBITDA	-1.8M -8.9M

Dividendi
By Dow Jones
Utili prossimi	7 mag 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	-124K 51M
Apertura precedente	0
Chiusura precedente	0

Vivesto AB Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

10 mar 2026, 20:38 UTC

Utili

Oracle Raises 2027 Sales Outlook Amid AI Demand, Restructuring

10 mar 2026, 23:57 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

10 mar 2026, 23:57 UTC

Discorsi di Mercato

Risks Rising on Australian Bank Valuation Multiples -- Market Talk

10 mar 2026, 23:47 UTC

Discorsi di Mercato

Nikkei May Rise as Concerns About Energy Costs Ease -- Market Talk

10 mar 2026, 23:37 UTC

Acquisizioni, Fusioni, Takeovers

Yangzijiang Shipbuilding to Acquire Poseidon Stake for US$825.7M

10 mar 2026, 23:37 UTC

Acquisizioni, Fusioni, Takeovers

Yangzijiang Shipbuilding to Buy 10% Stake in Poseidon

10 mar 2026, 23:37 UTC

Acquisizioni, Fusioni, Takeovers

Yangzijiang Shipbuilding to Fund Deal With Internal Cash Resources

10 mar 2026, 23:37 UTC

Acquisizioni, Fusioni, Takeovers

Yangzijiang Shipbuilding to Buy Stake From Fairfax, Washington Family Affiliates

10 mar 2026, 23:35 UTC

Discorsi di Mercato

Principali Notizie su Eventi

Gold Edges Higher as It Faces Opposing Forces -- Market Talk

10 mar 2026, 23:06 UTC

Utili

Oracle Raises 2027 Sales View as AI Demand Outpaces Supply -- Update

10 mar 2026, 22:51 UTC

Principali Notizie su Eventi

Deleted Tweet From Energy Secretary Sends Oil Markets on Another Wild Ride -- Updated

10 mar 2026, 21:39 UTC

Acquisizioni, Fusioni, Takeovers

Bill Ackman Has a Stroke of Genius. Buy His New Fund and Get Shares of His Pershing Square IPO. -- Barrons.com

10 mar 2026, 21:21 UTC

Utili

Oracle Stock Jumps on Earnings Beat. Its Cloud Business Is Taking Over. -- Barrons.com

10 mar 2026, 21:15 UTC

Utili

Franco-Nevada: 2026 Total GEOs Expected to Range From 510,000 to 570,000 Ounces

10 mar 2026, 21:15 UTC

Acquisizioni, Fusioni, Takeovers

Paramount Skydance's Stock Fades. The Warner Bros. Merger Will Take Years to Pay Off, BofA Says. -- Barrons.com

10 mar 2026, 21:14 UTC

Utili

Franco-Nevada: Methodology Replaces Previous Variable GEO Conversion Ratios Based on Prevailing Market Prices

10 mar 2026, 21:13 UTC

Utili

Franco-Nevada: Beginning in 2026, Company Will Be Adopt Fixed GEO Conversion Ratios Based on the Pricing Assumptions Outlined in 2026 Guidance

10 mar 2026, 21:12 UTC

Utili

Franco-Nevada 4Q Rev $597.3M >FNV

10 mar 2026, 21:12 UTC

Utili

Franco-Nevada 4Q EPS $1.90

10 mar 2026, 20:57 UTC

Utili

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10 mar 2026, 20:50 UTC

Discorsi di Mercato

Utili

Tech, Media & Telecom Roundup: Market Talk

10 mar 2026, 20:44 UTC

Utili

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10 mar 2026, 20:34 UTC

Discorsi di Mercato

Utili

Global Equities Roundup: Market Talk

10 mar 2026, 20:34 UTC

Discorsi di Mercato

Utili

Oracle Building More Software for Less Money After Restructuring -- Market Talk

10 mar 2026, 20:23 UTC

Utili

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10 mar 2026, 20:16 UTC

Utili

NIO Stock Jumps After Earnings. How the EV Maker Delivered a Surprise Profit. -- Barrons.com

10 mar 2026, 20:14 UTC

Utili

Oracle Has Not Yet Initiated At-The-Market Equity Portion of Financing Program >ORCL

10 mar 2026, 20:14 UTC

Utili

Oracle Said In February It Intends to Raise Up to $50 B Dollars in Debt and Equity Financing >ORCL

10 mar 2026, 20:13 UTC

Utili

Oracle Raised $30 B Through Combination of Investment Grade Bonds and Mandatory Convertible Preferred Stk Within Days of Feb Announcement >ORCL

10 mar 2026, 20:12 UTC

Utili

Oracle Stock Jumps on Earnings Beat -- Barrons.com

Confronto tra pari

Modifica del prezzo

Vivesto AB Previsione

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Vivesto AB

Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.